This article is more than 5 years old. Information may no longer be current.
Zimmer receives five patents for joint preservation procedure
Click Here to Manage Email Alerts
Zimmer Holdings Inc. announced the United States Patent and Trademark Office issued five new patents directed to the subchondroplasty procedure, a new joint preservation procedure developed by Zimmer Knee Creations.
According to a company press release, these patents broaden the coverage of the first subchondroplasty procedure patent issued to include new procedure methods, instrument kits, navigation systems, implants and other anatomical sites. The subchondroplasty procedure is a percutaneous outpatient intervention that reportedly addresses defects associated with subchondral bone marrow lesions. According to the release, the subchondroplasty procedure is the first procedure to treat bone-based changes within a joint, and addresses an unmet clinical need between early interventions, such as NSAIDs and joint arthroscopy, and total joint replacement.
“These valuable additions to our Subchondroplasty Procedure patent portfolio are the result of years of research and development,” Michael Simpson, vice president and general manager of Zimmer Knee Creations Inc., stated in the release. “The Subchondroplasty Procedure is a differentiated clinical solution which demonstrates Zimmer’s commitment to offering the most comprehensive range of therapies for patients across the continuum of care.”